Fibroblast growth factor 21, a biomarker for mitochondrial muscle disease
Neurology
.
2013 Nov 19;81(21):1808-9.
doi: 10.1212/01.wnl.0000436076.06159.2c.
Epub 2013 Oct 18.
Authors
Ralitza Gavrilova
1
,
Rita Horvath
Affiliation
1
From the Departments of Medical Genetics and Neurology (R.G.), Mayo Clinic, Rochester, MN; and Newcastle University (R.H.), Newcastle upon Tyne, UK.
PMID:
24142478
DOI:
10.1212/01.wnl.0000436076.06159.2c
No abstract available
Publication types
Editorial
Comment
MeSH terms
Female
Fibroblast Growth Factors*
Humans
Male
Mitochondrial Diseases / blood*
Muscular Diseases / blood*
Substances
fibroblast growth factor 21
Fibroblast Growth Factors
Grants and funding
096919/WT_/Wellcome Trust/United Kingdom